Article
Metabolomics study to identify plasma biomarkers in alzheimer disease: ApoE genotype effect.
Journal of pharmaceutical and biomedical analysis - 20 Feb 2020
Peña-Bautista Carmen, Roca Marta, López-Cuevas Rogelio, Baquero Miguel, Vento Máximo, Cháfer-Pericás Consuelo
Abstract excerpt
Alzheimer Disease (AD) is the main cause of dementia, and it has a great social and economic impact worldwide. It is a complex multifactorial disease, and we still do not know enough about its causes. For this reason, omics studies could be a useful tool for the search for new biomarkers and for enhancing the knowledge of different metabolic pathways that may be altered in the initial stages of the disease....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
